This educational activity is supported by unrestricted educational grants from Agios Pharmaceuticals, Inc.
Imagine living with excruciating pain triggered by a gentle cool breeze and rushing to the emergency department only to be denied pain medications. You are suspected of exhibiting drug-seeking behavior or simply denied help based on your race. Because of these unfounded suspicions you never see a sickle cell disease specialist or prescribed disease-specific medication despite multiple ischemic events. Systemic racism, uninformed providers, and limited funding in drug development continue to perpetuate health disparities in the sickle cell community. Learn how one health plan collaborated with a leading hematologist and nurse caregiver/patient advocate to address these care gaps.
The multi-disciplinary faculty will focus on managed care collaboration to address quality of life, inequitably access to care, the utility of disease-specific medications and future gene therapy, and actionable payer strategies that emphasize complex patient care in sickle cell disease.
- Recognize the physical, emotional, and financial impact to quality of life the sickle cell disease community experiences perpetuated by the current state.
- Describe the implicit and explicit social biases rooted in the care delivery and management of sickle cell disease.
- Review the utility of current disease-specific medications and future gene therapy options for the management of sickle cell disease.
- Discuss actionable strategies that payers can implement to ensure fair access to necessary treatment and close gaps in multi-dimensional care coordination between various providers and sites of service.
Andrew Campbell, MD
Director, Comprehensive Sickle Cell Disease Program
Children's National Medical Center, Washington DC
Washington, District of Columbia, MD
Max Lee, PharmD
Former Pharmacy Resident
Premera Blue Cross
Francesca C. Valentine, MSN, RN
Medical advisory board , Patient advocate
Sick Cells 501 (C) (3) Organization
Sharon M. Montgomery, PharmBS
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-21-049-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: October 20, 2021 • Expiration Date: December 31, 2022
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP Nexus 2021. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements:
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-21-049-H01-P||1.25 Contact Hours||October 20, 2021 - December 31, 2022|